Evidence map›Paper›PMID 37731497›Full record

ArticleFrontiers in immunology2023

Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry data.

Ravi K Patel, Rebecca G Jaszczak, Kwok Im, Nicholas D Carey, Tristan Courau, Daniel G Bunis, Bushra Samad, Lia Avanesyan, Nayvin W Chew, Sarah Stenske and 11 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. LANA-specific CD4Nature communications · 2025
    Article
  5. Article
  6. Dysregulation of CD4Journal for immunotherapy of cancer · 2024
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Ravi K PatelUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Rebecca G JaszczakUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Kwok ImUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Nicholas D CareyUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Tristan CourauUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Daniel G BunisUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Bushra SamadUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Lia AvanesyanDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, United States.
Nayvin W ChewUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Sarah StenskeDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, United States.
Jillian M JespersenDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, United States.
Jean PublicoverDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, United States.
Austin W EdwardsUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Mohammad NaserUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Arjun A RaoUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Leonard Lupin-JimenezUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Matthew F KrummelDepartment of Pathology, University of California San Francisco, San Francisco, CA, United States.
Stewart CooperUCSF Liver Center, University of California San Francisco, San Francisco, CA, United States.
Jody L BaronDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, United States.
Alexis J CombesUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.
Gabriela K FragiadakisUCSF CoLabs, University of California San Francisco, San Francisco, CA, United States.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Y. Chen · 1986 to 2026
$30.7M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
Supplement to A Multi-omics Approach to Immune Responses in HIV Vaccination and InterventionP01AI178375 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DENNIS J. HARTIGAN-O'CONNOR, Rachel Lena Rutishauser · 2023 to 2026
$8.5M
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis BR01DK103735 · NIDDK · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI BARON, JODY L, COOPER, STEWART · 2016 to 2025
$7.2M
NCI NIH HHS T32 CA108462NIAID NIH HHS P01 AI178375NIAID NIH HHS T32 AI007334NIAMS NIH HHS P30 AR070155NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK103735
6 · The paper itself

Abstract

In the past decade, high-dimensional single-cell technologies have revolutionized basic and translational immunology research and are now a key element of the toolbox used by scientists to study the immune system. However, analysis of the data generated by these approaches often requires clustering algorithms and dimensionality reduction representation, which are computationally intense and difficult to evaluate and optimize. Here, we present Cytometry Clustering Optimization and Evaluation (Cyclone), an analysis pipeline integrating dimensionality reduction, clustering, evaluation, and optimization of clustering resolution, and downstream visualization tools facilitating the analysis of a wide range of cytometry data. We benchmarked and validated Cyclone on mass cytometry (CyTOF), full-spectrum fluorescence-based cytometry, and multiplexed immunofluorescence (IF) in a variety of biological contexts, including infectious diseases and cancer. In each instance, Cyclone not only recapitulates gold standard immune cell identification but also enables the unsupervised identification of lymphocytes and mononuclear phagocyte subsets that are associated with distinct biological features. Altogether, the Cyclone pipeline is a versatile and accessible pipeline for performing, optimizing, and evaluating clustering on a variety of cytometry datasets, which will further power immunology research and provide a scaffold for biological discovery.

Indexed as

Cyclonic StormsAlgorithmsBenchmarkingCluster AnalysisTechnologyclustering optimizationcycloneCyTOFFlowSOMmulti-parametric analysisspatial expression dataspectral flow cytometry

Identifiers

PMID37731497
PMCPMC10507399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.